2026
Sep (2)
Jul (2)
Jun (2)
May (2)
Apr (4)
Mar (2)
Feb (4)
Jan (1)
2024
Jun (2)
May (1)
Apr (1)
Mar (1)
2023
Sep (1)
2019
Mar (1)
2018
Dec (1)
Nov (2)
Jun (1)
Mar (1)
Jan (1)
2017
Sep (1)
Jul (1)
Apr (1)
2016
Oct (2)
Sep (1)
Jun (1)
Mar (1)
Feb (1)
2015
Oct (1)
Sep (1)
Jul (3)
2004
Jul (3)
Jun (2)
Feb (1)
Jan (2)
2003
Dec (1)
Aug (2)
Jul (1)
Jun (3)
Apr (1)
Mar (1)
Feb (1)
Jan (2)
2002
Dec (1)
Nov (1)
September 2026
September 5, 2026
CDK2 Inhibitors May Enhance Immunotherapy for a Broader Range of Cancers
Research from Dana-Farber Cancer Institute indicates that CDK2 inhibitors may enhance immunotherapy effectiveness across various cancers, expanding treatment options. This development could impact cancer treatment…
September 1, 2026
AI-Driven AdaptiveFlow Revolutionizes Cost-Effective Drug Discovery
Researchers have developed AdaptiveFlow, an AI-informed platform that significantly reduces the computational costs of virtual drug screening, enabling routine large-scale drug discovery. The platform was…